Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2020-09-11

Clinical Trial Update: Gentamicin Treatment Prior to Schwannoma Surgery - No Residual Function [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating gentamicin treatment before Schwannoma surgery was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gentamicin (gentamicin)

Snippet

Sponsor: Lund University | Conditions: Vestibular Schwannoma | Phase 4 | Status: WITHDRAWN